PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Critical Care, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, USA.\', \'Division of Hematology and Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA. rprosovsky@partners.org.\', \'Division of Hematology and Oncology, National Institutes of Health, Bethesda, MD, USA.\', \'Department of Surgery, Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital, Boston, MA, USA.\', \'Division of Cardiac Anesthesia and Critical Care, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, USA. mgchang@partners.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13054-020-03273-y
?:doi
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32938471
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all